Article Versions Notes

Busch MH, Timmermans SAMEG, Aendekerk JP, Ysermans R, Amiral J, Damoiseaux JGMC, Reutelingsperger CP, Paassen Pv. Annexin A1 Is Associated with Adverse Clinical Outcomes in Patients with COVID-19. Journal of Clinical Medicine. 2022; 11(24):7486. https://doi.org/10.3390/jcm11247486

Busch, Matthias H., Sjoerd A. M. E. G. Timmermans, Joop P. Aendekerk, Renée Ysermans, Jean Amiral, Jan G. M. C. Damoiseaux, Chris P. Reutelingsperger, and Pieter van Paassen. 2022. "Annexin A1 Is Associated with Adverse Clinical Outcomes in Patients with COVID-19" Journal of Clinical Medicine 11, no. 24: 7486. https://doi.org/10.3390/jcm11247486

Busch, M. H., Timmermans, S. A. M. E. G., Aendekerk, J. P., Ysermans, R., Amiral, J., Damoiseaux, J. G. M. C., Reutelingsperger, C. P., & Paassen, P. v. (2022). Annexin A1 Is Associated with Adverse Clinical Outcomes in Patients with COVID-19. Journal of Clinical Medicine, 11(24), 7486. https://doi.org/10.3390/jcm11247486